Neurodyn Life Sciences Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Neurodyn Life Sciences Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11193
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:23
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Neurodyn Life Sciences Inc (Neurodyn Life Sciences), formerly Neurodyn Inc is a provider of validation and development of bioactives for neuroprotection and early treatment of neurological diseases. The company’s products include neuroprotectant, memogain, progranulin, and nerve pain treatment. Its Neuroprotectant, is a saponin based bioactive that is used for protection of early stage Parkinson’s disease, Progranulin is a bioactive used for the neuroprotection and treatment of Parkinson’s disease, and nerve pain treatment is a lipophilic compound that acts as an antagonists for sodium and TRP ion channels. Neurodyn Life Sciences develops bioactives for neuroprotection and for treating neurological diseases. The company also provides contract research services for medicinal chemistry. It caters to pharmaceutical and consumer health players. Neurodyn Life Sciences is headquartered in Charlottetown, Canada.

Neurodyn Life Sciences Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Neurodyn Life Sciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Neurodyn Life Sciences Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Neurodyn Life Sciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Neurodyn Life Sciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Neurodyn Life Sciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Neurodyn Life Sciences Inc, Pharmaceuticals & Healthcare, Deal Details 10
Asset Purchase 10
Neurodyn Acquires Memogain Related Assets From Galantos Pharma 10
Venture Financing 11
Neurodyn Cognition Raises USD0.2 Million in Venture Financing 11
Neurodyn Cognition Raises USD0.4 Million in Venture Financing 12
Neurodyn Raises USD0.4 Million Financing 13
Neurodyn Life Sciences Raises Funds Through Venture Financing 14
Neurodyn Life Sciences Raises USD0.6 Million in Venture Financing 15
Neurodyn Life Sciences Raises USD0.3 Million in Venture Financing 16
Neurodyn Raises US$1.5 Million In Series A Financing 17
Neurodyn Raises US$0.13 Million In Venture Financing 18
Equity Offering 19
Neurodyn Raises USD0.8 Million in Private Placement of Shares 19
Neurodyn Life Sciences Inc – Key Competitors 20
Neurodyn Life Sciences Inc – Key Employees 21
Neurodyn Life Sciences Inc – Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List of Tables
Neurodyn Life Sciences Inc, Pharmaceuticals & Healthcare, Key Facts 2
Neurodyn Life Sciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Neurodyn Life Sciences Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Neurodyn Life Sciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Neurodyn Life Sciences Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Neurodyn Life Sciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Neurodyn Acquires Memogain Related Assets From Galantos Pharma 10
Neurodyn Cognition Raises USD0.2 Million in Venture Financing 11
Neurodyn Cognition Raises USD0.4 Million in Venture Financing 12
Neurodyn Raises USD0.4 Million Financing 13
Neurodyn Life Sciences Raises Funds Through Venture Financing 14
Neurodyn Life Sciences Raises USD0.6 Million in Venture Financing 15
Neurodyn Life Sciences Raises USD0.3 Million in Venture Financing 16
Neurodyn Raises US$1.5 Million In Series A Financing 17
Neurodyn Raises US$0.13 Million In Venture Financing 18
Neurodyn Raises USD0.8 Million in Private Placement of Shares 19
Neurodyn Life Sciences Inc, Key Competitors 20
Neurodyn Life Sciences Inc, Key Employees 21
Neurodyn Life Sciences Inc, Subsidiaries 22

List of Figures
Neurodyn Life Sciences Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Neurodyn Life Sciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Neurodyn Life Sciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Neurodyn Life Sciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Neurodyn Life Sciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Neurodyn Life Sciences Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Neurodyn Life Sciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Neurodyn Life Sciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Neurodyn Life Sciences Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Guided Therapeutics Inc (GTHP):企業の財務・戦略的SWOT分析
    Summary Guided Therapeutics Inc (GTI), formerly SpectRx Inc is a biotechnology company that offers platform technology for the early detection of disease that leads to cancer. The company provides products for the non-invasive cervical cancer detection markets. Its products include luviva, a non-inv …
  • Sebia SA:製品パイプライン分析
    Summary Sebia SA (Sebia) is a medical device company that designs, manufactures, commercializes, and exports electrophoresis tests and analyzers for diagnosis of cancer. The company's electrophoresis program offer automated system for capillary electrophoresis, gel electrophoresis and electrophoresi …
  • Rexnord Corp (RXN):電力:M&Aディール及び事業提携情報
    Summary Rexnord Corp (Rexnord) offers process and motion control, and water management products. The company designs, manufactures, markets and services mechanical components, and water flow control and conservation products. Its product portfolio includes motion control products, aerospace componen …
  • ALFA, S.A.B. de C.V.:企業の戦略・SWOT・財務情報
    ALFA, S.A.B. de C.V. - Strategy, SWOT and Corporate Finance Report Summary ALFA, S.A.B. de C.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Arbuthnot Banking Group Plc:企業の戦略・SWOT・財務情報
    Arbuthnot Banking Group Plc - Strategy, SWOT and Corporate Finance Report Summary Arbuthnot Banking Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • First American Financial Corporation:企業のM&A・事業提携・投資動向
    First American Financial Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's First American Financial Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports …
  • Hydro Ottawa Holding Inc:企業の戦略的SWOT分析
    Hydro Ottawa Holding Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • DKSH Holding Ltd (DKSH):企業の財務・戦略的SWOT分析
    DKSH Holding Ltd (DKSH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Cognizant Technology Solutions Corporation:戦略・SWOT・企業財務分析
    Cognizant Technology Solutions Corporation - Strategy, SWOT and Corporate Finance Report Summary Cognizant Technology Solutions Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, …
  • Orpea SA (ORP):企業の財務・戦略的SWOT分析
    Summary Orpea SA (Orpea) is a healthcare consulting company that offers clinical care services. The company provides services such as suite care clinic services, retirement homes, and mental hospital services, among others. Its mental hospital services include treatment of mood disorders, overuse sy …
  • British Arab Commercial Bank plc:企業の戦略的SWOT分析
    British Arab Commercial Bank plc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • INC Research LLC-製薬・医療分野:企業M&A・提携分析
    Summary INC Research LLC (INC Research), a subsidiary of INC Research Holdings Inc is a healthcare services provider that offers contract research services. The organization provides phase I to IV clinical development services. Its services include study start-up, INC pressure test, INC patient elig …
  • Seven & i Holdings Co., Ltd.:企業の戦略・SWOT・財務分析
    Seven & i Holdings Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Seven & i Holdings Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Old Dominion Freight Line Inc (ODFL):企業の財務・戦略的SWOT分析
    Old Dominion Freight Line Inc (ODFL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • The Nippon Synthetic Chemical Industry Co Ltd:企業の戦略的SWOT分析
    The Nippon Synthetic Chemical Industry Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors …
  • Cooper Energy Ltd Oil & Gas Exploration and Production Operations and Cost Analysis – 2017
    Cooper Energy Ltd Oil & Gas Exploration and Production Operations and Cost Analysis - 2017 Summary Cooper Energy Limited (CEL) is an exploration and production company that offers oil production programs. The company explores, produces, and commercializes crude oil and natural gas products. It condu …
  • Century Enka Limited:企業の戦略・SWOT・財務分析
    Century Enka Limited - Strategy, SWOT and Corporate Finance Report Summary Century Enka Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • ATI Physical Therapy-製薬・医療分野:企業M&A・提携分析
    Summary ATI Physical Therapy (ATI) is a healthcare service provider that offers therapy services. The center offers therapy services such as physical therapy, workers' comp rehab, sports therapy, hand therapy, women's health, specialty therapies, home health and complimentary injury screening servic …
  • Emirates Flight Catering:企業の戦略・SWOT・財務分析
    Emirates Flight Catering - Strategy, SWOT and Corporate Finance Report Summary Emirates Flight Catering - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • National Power Corporation:企業の戦略的SWOT分析
    National Power Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆